Pulse Biosciences, Inc. (PLSE)
NASDAQ · Healthcare
Pulse Biosciences, Inc. Shareholder Equity 2020–2025
Pulse Biosciences, Inc. annual/quarterly shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Pulse Biosciences, Inc. shareholder equity for the quarter ending December 31, 2025 were 80.7M, a 29.78% decrease year-over-year.
- Pulse Biosciences, Inc. shareholder equity for 2025 were 80.7M, a 29.78% decrease from 2024.
- Pulse Biosciences, Inc. shareholder equity for 2024 were 114.9M, a 158.93% increase from 2023.
- Pulse Biosciences, Inc. shareholder equity for 2023 were 44.4M, a 2073.31% decrease from 2022.
- Pulse Biosciences, Inc. shareholder equity for 2022 were -2.2M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Pulse Biosciences, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $81 |
| 2024 | $115 |
| 2023 | $44 |
| 2022 | $-2 |
| 2021 | $44 |
| 2020 | $23 |
| Pulse Biosciences, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $81 |
| 2024-12-31 | $115 |
| 2023-12-31 | $44 |
| 2022-12-31 | $-2 |
| 2021-12-31 | $44 |
| 2020-12-31 | $23 |
Pulse Biosciences, Inc. Shareholder Equity — FAQ
Pulse Biosciences, Inc. (PLSE) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PLSE's shareholder equity history?
The chart and table above show Pulse Biosciences, Inc.'s shareholder equity by year and by quarter, including the growth rate.